Cargando…

Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi

BACKGROUND: Malawi, which has about 80 000 deaths from AIDS every year, made free antiretroviral therapy available to more than 80 000 patients between 2004 and 2006. We aimed to investigate mortality in a population before and after the introduction of free antiretroviral therapy, and therefore to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jahn, Andreas, Floyd, Sian, Crampin, Amelia C, Mwaungulu, Frank, Mvula, Hazzie, Munthali, Fipson, McGrath, Nuala, Mwafilaso, Johnbosco, Mwinuka, Venance, Mangongo, Bernard, Fine, Paul EM, Zaba, Basia, Glynn, Judith R
Formato: Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387197/
https://www.ncbi.nlm.nih.gov/pubmed/18468544
http://dx.doi.org/10.1016/S0140-6736(08)60693-5
_version_ 1782155299924213760
author Jahn, Andreas
Floyd, Sian
Crampin, Amelia C
Mwaungulu, Frank
Mvula, Hazzie
Munthali, Fipson
McGrath, Nuala
Mwafilaso, Johnbosco
Mwinuka, Venance
Mangongo, Bernard
Fine, Paul EM
Zaba, Basia
Glynn, Judith R
author_facet Jahn, Andreas
Floyd, Sian
Crampin, Amelia C
Mwaungulu, Frank
Mvula, Hazzie
Munthali, Fipson
McGrath, Nuala
Mwafilaso, Johnbosco
Mwinuka, Venance
Mangongo, Bernard
Fine, Paul EM
Zaba, Basia
Glynn, Judith R
author_sort Jahn, Andreas
collection PubMed
description BACKGROUND: Malawi, which has about 80 000 deaths from AIDS every year, made free antiretroviral therapy available to more than 80 000 patients between 2004 and 2006. We aimed to investigate mortality in a population before and after the introduction of free antiretroviral therapy, and therefore to assess the effects of such programmes on survival at the population level. METHODS: We used a demographic surveillance system to measure mortality in a population of 32 000 in northern Malawi, from August, 2002, when free antiretroviral therapy was not available in the study district, until February, 2006, 8 months after a clinic opened. Causes of death were established through verbal autopsies (retrospective interviews). Patients who registered for antiretroviral therapy at the clinic were identified and linked to the population under surveillance. Trends in mortality were analysed by age, sex, cause of death, and zone of residence. FINDINGS: Before antiretroviral therapy became available in June, 2005, mortality in adults (aged 15–59 years) was 9·8 deaths for 1000 person-years of observation (95% CI 8·9–10·9). The probability of dying between the ages of 15 and 60 years was 43% (39–49) for men and 43% (38–47) for women; 229 of 352 deaths (65·1%) were attributed to AIDS. 8 months after the clinic that provided antiretroviral therapy opened, 107 adults from the study population had accessed treatment, out of an estimated 334 in need of treatment. Overall mortality in adults had decreased by 10% from 10·2 to 8·7 deaths for 1000 person-years of observation (adjusted rate ratio 0·90, 95% CI 0·70–1·14). Mortality was reduced by 35% (adjusted rate ratio 0·65, 0·46–0·92) in adults near the main road, where mortality before antiretroviral therapy was highest (from 13·2 to 8·5 deaths per 1000 person-years of observation before and after antiretroviral therapy). Mortality in adults aged 60 years or older did not change. INTERPRETATION: Our findings of a reduction in mortality in adults aged between 15 and 59 years, with no change in those older than 60 years, suggests that deaths from AIDS were averted by the rapid scale-up of free antiretroviral therapy in rural Malawi, which led to a decline in adult mortality that was detectable at the population level. FUNDING: Wellcome Trust and British Leprosy Relief Association.
format Text
id pubmed-2387197
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Lancet Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23871972008-06-06 Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi Jahn, Andreas Floyd, Sian Crampin, Amelia C Mwaungulu, Frank Mvula, Hazzie Munthali, Fipson McGrath, Nuala Mwafilaso, Johnbosco Mwinuka, Venance Mangongo, Bernard Fine, Paul EM Zaba, Basia Glynn, Judith R Lancet Articles BACKGROUND: Malawi, which has about 80 000 deaths from AIDS every year, made free antiretroviral therapy available to more than 80 000 patients between 2004 and 2006. We aimed to investigate mortality in a population before and after the introduction of free antiretroviral therapy, and therefore to assess the effects of such programmes on survival at the population level. METHODS: We used a demographic surveillance system to measure mortality in a population of 32 000 in northern Malawi, from August, 2002, when free antiretroviral therapy was not available in the study district, until February, 2006, 8 months after a clinic opened. Causes of death were established through verbal autopsies (retrospective interviews). Patients who registered for antiretroviral therapy at the clinic were identified and linked to the population under surveillance. Trends in mortality were analysed by age, sex, cause of death, and zone of residence. FINDINGS: Before antiretroviral therapy became available in June, 2005, mortality in adults (aged 15–59 years) was 9·8 deaths for 1000 person-years of observation (95% CI 8·9–10·9). The probability of dying between the ages of 15 and 60 years was 43% (39–49) for men and 43% (38–47) for women; 229 of 352 deaths (65·1%) were attributed to AIDS. 8 months after the clinic that provided antiretroviral therapy opened, 107 adults from the study population had accessed treatment, out of an estimated 334 in need of treatment. Overall mortality in adults had decreased by 10% from 10·2 to 8·7 deaths for 1000 person-years of observation (adjusted rate ratio 0·90, 95% CI 0·70–1·14). Mortality was reduced by 35% (adjusted rate ratio 0·65, 0·46–0·92) in adults near the main road, where mortality before antiretroviral therapy was highest (from 13·2 to 8·5 deaths per 1000 person-years of observation before and after antiretroviral therapy). Mortality in adults aged 60 years or older did not change. INTERPRETATION: Our findings of a reduction in mortality in adults aged between 15 and 59 years, with no change in those older than 60 years, suggests that deaths from AIDS were averted by the rapid scale-up of free antiretroviral therapy in rural Malawi, which led to a decline in adult mortality that was detectable at the population level. FUNDING: Wellcome Trust and British Leprosy Relief Association. Lancet Publishing Group 2008-05-10 /pmc/articles/PMC2387197/ /pubmed/18468544 http://dx.doi.org/10.1016/S0140-6736(08)60693-5 Text en 2008 Elsevier Ltd. All rights reserved. This document may be redistributed and reused, subject to certain conditions (http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0) .
spellingShingle Articles
Jahn, Andreas
Floyd, Sian
Crampin, Amelia C
Mwaungulu, Frank
Mvula, Hazzie
Munthali, Fipson
McGrath, Nuala
Mwafilaso, Johnbosco
Mwinuka, Venance
Mangongo, Bernard
Fine, Paul EM
Zaba, Basia
Glynn, Judith R
Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi
title Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi
title_full Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi
title_fullStr Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi
title_full_unstemmed Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi
title_short Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi
title_sort population-level effect of hiv on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in malawi
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387197/
https://www.ncbi.nlm.nih.gov/pubmed/18468544
http://dx.doi.org/10.1016/S0140-6736(08)60693-5
work_keys_str_mv AT jahnandreas populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT floydsian populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT crampinameliac populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT mwaungulufrank populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT mvulahazzie populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT munthalifipson populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT mcgrathnuala populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT mwafilasojohnbosco populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT mwinukavenance populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT mangongobernard populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT finepaulem populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT zababasia populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi
AT glynnjudithr populationleveleffectofhivonadultmortalityandearlyevidenceofreversalafterintroductionofantiretroviraltherapyinmalawi